MedTrace Logo

High Flow Nasal Cannula for Stabilization of Extremely Premature Infants

NCT06683677 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-11-14

No results posted yet for this study

Summary

A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize extremely preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 6-8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low Saturation of oxygen (SpO2).

Conditions

  • Premature Infant
  • Ventilation Therapy
  • High Flow Nasal Canula

Interventions

DEVICE

High-Flow Nasal Cannula

The intervention involves administering High-Flow Nasal Cannula therapy to extremely preterm infants immediately after birth.

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Minutes
Max Age
2 Minutes
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2028-12-31
Completion
2029-07-01

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06683677 on ClinicalTrials.gov